Diabetic Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Diabetic Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
This clinical trial update reports on using in vivo corneal confocal microscopy as a non-invasive method to assess diabetic peripheral neuro…
-
FDA approval · 2015-10-28FDA Approved: DULOXETINE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original ANDA for duloxetine, allowing a generic version to be marketed. The approval covers duloxetin…
-
CLINICAL_TRIALS withdrawal · 2015-09-28Clinical Trial Update: Laser Therapy for Diabetic Peripheral Neuropathic Pain [Phase 2]
A Phase 2 clinical trial evaluating laser therapy for diabetic peripheral neuropathy has been withdrawn, sponsored by the University of Miam…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]
Phase 2 safety and efficacy study of ADL5859 in neuropathic pain associated with diabetic peripheral neuropathy; the trial is completed with…
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Cognitive Behavioral Therapy for Diabetic Neuropathic Pain [NA]
Completed clinical trial evaluating cognitive behavioral therapy for diabetic peripheral neuropathy; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy [Phase 2]
A Phase 2 multicenter randomized double-blind placebo-controlled study for painful diabetic neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Evaluation of Exenatide in Patients With Diabetic Neuropathy [NA]
A completed clinical trial evaluating exenatide in patients with type 2 diabetes mellitus and diabetic peripheral neuropathy has posted resu…
-
CLINICAL_TRIALS withdrawal · 2015-03-17Clinical Trial Update: Neuragen for Peripheral Diabetic Neuropathy [Phase 3]
A Phase 3 trial of Neuragen for diabetic peripheral neuropathy and diabetic neuralgia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN) [Phase 3]
Phase 3 study evaluating the efficacy and safety of a single application of an 8% capsaicin transdermal patch versus placebo in reducing pai…
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of CBX129801 in patients with Type 1 diabetes and diabetic peripheral neuropathy; the s…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Validation Study of Neuropathic Pain
A completed validation study of neuropathic pain conditions, including spinal cord injury-related neuropathic pain, diabetic peripheral neur…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Ultrasonographic Evaluation of Diabetic Neuropathy
A completed clinical trial from Cukurova University evaluated ultrasonographic assessment of diabetic peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN) [Phase 3]
Phase 3 trial assessing efficacy and safety of pregabalin for pain on walking in diabetic peripheral neuropathy; study completed with result…
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy [Phase 2]
A Phase 2 trial comparing CNV2197944 to placebo in patients with Diabetic Peripheral Neuropathy has completed, reporting on efficacy and saf…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients
A completed post-marketing surveillance study evaluated the safety and efficacy of duloxetine (Cymbalta) for diabetic peripheral neuropathic…
-
FDA approval · 2014-06-11FDA Approved: DULOXETINE DELAYED-RELEASE — Original Application (Breckenridge Pharmaceutical, Inc.)
FDA approved Breckenridge Pharmaceutical's original generic duloxetine hydrochloride delayed-release capsules, a generic version of the anti…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management [Phase 4]
Phase 4 trial comparing gabapentin with B-complex versus pregabalin for diabetic peripheral neuropathy pain reported efficacy and safety res…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Restoration of Cutaneous Sensorum in Patients With Diabetic Peripheral Neuropathy (DPN) Via Metanx® [NA]
A completed clinical trial evaluating Metanx for restoration of cutaneous sensation in patients with diabetic peripheral neuropathy.
-
CLINICAL_TRIALS research · 2014-01-17Clinical Trial Update: A Study of Xuebi Formula for Diabetic Peripheral Neuropathy(Qi-deficiency and Blood-stasis) [NA]
This clinical trial update describes a study of Xuebi Formula for diabetic peripheral neuropathy, with diabetes as a co-condition; the trial…
-
FDA approval · 2014-01-16FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Tapentadol hydrochloride (generic) submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Diffusion Tensor Imaging of Sural Nerves in Diabetic Peripheral Neuropathy
A completed clinical trial evaluating diffusion tensor imaging of sural nerves in patients with diabetic peripheral neuropathy.
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' original application for a generic duloxetine product (DULOXETINE). This approval allows the mar…
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic duloxetine under an Original Application, authorizing a generic version of the reference duloxet…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN) [Phase 4]
Phase 4 study of Metanx for diabetic peripheral neuropathy completed; results posted in 2013.
-
FDA approval · 2013-07-12FDA Approved: GABAPENTIN — Original Application (ACI Healthcare USA, Inc.)
FDA approved a generic gabapentin product under an Original Application filed by ACI Healthcare USA, Inc.